Evidence map›Paper›PMID 34612610›Full record

ArticleAnnals of clinical and translational neurology2021

Exploring diazoxide and continuous glucose monitoring as treatment for Glut1 deficiency syndrome.

Santhi N Logel, Ellen L Connor, David A Hsu, Rachel J Fenske, Neil J Paloian, Darryl C De Vivo

Open access · goldAbstract readCase Reports
In one paragraph

Article in Annals of clinical and translational neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Santhi N LogelDivision of Pediatric Endocrinology and Diabetes, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.ORCID 0000-0003-2028-8518
Ellen L ConnorDivision of Pediatric Endocrinology and Diabetes, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.ORCID 0000-0002-9667-7002
David A HsuDepartment of Neurology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.ORCID 0000-0002-8343-0406
Rachel J FenskeClinical Nutrition, University of Wisconsin Hospital and Clinics, Madison, Wisconsin, USA.ORCID 0000-0002-5417-0780
Neil J PaloianDivision of Pediatric Nephrology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.ORCID 0000-0003-4945-9480
Darryl C De VivoDepartments of Neurology and Pediatrics, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0001-8420-0795
University of Wisconsin–Madison · USColumbia University Irving Medical Center · USUW Health University Hospital · US

Funding

Childhood Diabetes Clinical & Molecular Research Training ProgramT32DK077586 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI Brigid Ellen Gregg, Scott B. Reeder · 2008 to 2026
$2.4M
NIDDK NIH HHS T32 DK077586
6 · The paper itself

Abstract

Glut1 deficiency syndrome is caused by SLC2A1 mutations on chromosome 1p34.2 that impairs glucose transport across the blood-brain barrier resulting in hypoglycorrhachia and decreased fuel for brain metabolism. Neuroglycopenia causes a drug-resistant metabolic epilepsy due to energy deficiency. Standard treatment for Glut1 deficiency syndrome is the ketogenic diet that decreases the demand for brain glucose by supplying ketones as alternative fuel. Treatment options are limited if patients fail the ketogenic diet. We present a case of successful diazoxide use with continuous glucose monitoring in a patient with Glut1 deficiency syndrome who did not respond to the ketogenic diet.

Indexed as

Blood Glucose Self-MonitoringAdolescentCarbohydrate Metabolism, Inborn ErrorsDiazoxideFemaleHumansMembrane Transport ModulatorsMonosaccharide Transport ProteinsSeizuresDiazoxideMembrane Transport ModulatorsMonosaccharide Transport Proteins

Identifiers

PMID34612610
PMCPMC8607448
OpenAlexW3204583818

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.